The visit was short and the conclusion was tidy: your labs are normal. What you brought in was harder to tidy. You are tired in a way that sleep does not seem to reach, the weight has gone on, and your drive, in the broad sense and the narrow one, is lower than it used to be. Reading the printout afterwards, you notice what is missing: no testosterone, no free testosterone, and nothing that amounts to a proper read of your thyroid.
If you have typed some version of low drive with normal labs into a search bar, the next question tends to be practical. If you start with someone new, how fast do you hear from a clinician, and how often after that? This piece answers that plainly for someone in exactly this position, including the parts GoodLife Health will not promise.
- A panel that never included testosterone, free testosterone or a full thyroid read cannot call those markers normal.
- The first thing you hear is whether a clinician accepts you: if not, the $598 is refunded in full; once accepted, the first two months are non-refundable.
- Messaging is asynchronous; in direct primary care, replies typically come same-day or next-day, and we publish no stopwatch figure.
- Four lab panels a year, with follow-up labs at 6–8 weeks if hormone therapy starts and about 90 days for metabolic changes.
- $299 a month, month to month after the first two; testosterone is never promised, and the clinician decides where the law allows.
Told "normal" by a panel that skipped the question
A panel answers the questions it was ordered to answer. Whatever yours covered, each result landed inside its reference range, and that is worth knowing. It says nothing about the markers that were never drawn. Fatigue, weight gain and low drive have more than one possible explanation, and the tests that would begin to separate them were left off the order.
It is also hard to raise all three in a short appointment. Traditional primary care runs on 15 to 20 minutes and one complaint per visit, as our walk-through of what a direct primary care visit actually looks like sets out. Low drive is the symptom many people mention last, with a hand on the door, if they mention it at all. When the visit closes on the word normal, it can feel as though the question was answered when it was never fully asked.
That leaves you with three unappealing choices. You can wait and see whether it lifts. You can ask again and risk hearing the same word. Or you can go somewhere that promises to be quick. Speed is what much of the market sells to someone in your position, and speed is easy to offer when the visit ends in a prescription whichever way the numbers fall.
So the question in the title deserves a careful answer. You are right to care how fast you hear back. You have already spent time feeling like this, and a membership that left you waiting weeks for a reply would repeat the experience you are trying to leave. What the speed is aimed at matters as much as the speed itself. A quick answer built on one number, or on none, is the same dismissal with a better response time.
What normal leaves out, and why the cadence matters
Normal is a population range. You are not a population. A result inside the range tells you where you sit among many people; it cannot speak for a marker nobody measured, and it cannot tell you how your own numbers are moving. For this cluster of symptoms the first useful step is a fuller panel, read as a whole.
At GoodLife Health the panel is drawn before your first visit. It includes a metabolic panel, a lipid panel, HbA1c, a hormone panel, TSH, fasting insulin and a blood count. The hormone read covers thyroid (TSH, free T3 and free T4), total and free testosterone and DHEA-S, alongside the metabolic markers, as our piece on bioidentical hormone therapy at pharmacy cost describes. Testosterone in particular is read with care: a morning draw, a repeat before anyone reaches a conclusion, and SHBG and free testosterone beside the total.
One afternoon number is not a diagnosis, either way. Testosterone is read from a morning draw and a repeat, with free testosterone, SHBG and the metabolic markers beside it.
The field is moving in this direction, and the movement shows up in dated facts. Labs-first care orders the panel before the visit, so the first conversation starts with data. Our 2026 guide documents direct primary care visits of 30 to 60 minutes against 15 to 20 in traditional care, with a quarterly review replacing the annual physical as the moment someone looks at the whole picture. In September 2026 the makers of Wegovy and Zepbound were publishing their own self-pay prices, so the price of a branded medication can be checked by anyone before it is prescribed. That is the model the Cardiometabolic Optimization definitive guide lays out: diagnosis first, then treatment, then the long haul.
Then there is the second half of the title: how often. A single panel is a photograph. Energy, weight and drive change over months, and so do the markers beside them. What turns a set of results into a diagnosis, or into a confident finding that the cause lies elsewhere, is the same clinician reading the next panel against the last one. That is why the membership runs on four cardiometabolic panels a year, each a Biomarker Audit, with every result in your hands and one clinician reading the sequence.
The speed that matters is how soon someone draws the markers nobody drew, and how reliably the same clinician reads the next set.
It is worth saying what a full panel might show, because honesty here protects you from a different kind of disappointment. It may point to testosterone, to thyroid, to insulin, or to more than one of them. It may come back unremarkable. That result has value too: it moves the conversation elsewhere with evidence instead of a shrug, and it gives you a baseline that the next quarter can be measured against.
How fast you hear back, how often, and what it costs
The first answer: whether you are accepted
The path has four steps: the eligibility check, the intake, the checkout, then a clinician's review. The first thing you hear from a clinician is whether you are accepted into care. We do not publish a guaranteed turnaround for that review, and this piece will not invent one. What we can tell you is what happens either way. If the clinician cannot accept you, the $598 paid at checkout is refunded in full. Once you are accepted, the first two months are non-refundable. Not everyone is accepted, and an acceptance means a clinician has read your intake and judged that this model fits you.
The first panel and the first visit
Once you are in, labs come first. They are drawn at a local LabCorp or Quest location, and the results go to your clinician before you meet, so the first video visit opens with your numbers already read. In the direct primary care model the first visit typically runs 45 to 60 minutes and follow-ups 20 to 30. Bring all three symptoms and anything else on your mind; the format is built for more than one concern, and it ends with a plan: what to do now, what to recheck and when, and what to message about if something changes.
Between visits: messages on your schedule
Messaging with the care team is asynchronous. You write when it suits you, at six in the morning before a flight or late after a long day, and the reply comes once a clinician has read your message against your chart. In the direct primary care model replies typically arrive same-day or next-day, compared with the two-to-three-week wait for another appointment in traditional care. We would rather give you that honest frame than a stopwatch figure we cannot stand behind. There is no copay for a message, and the monthly fee is the same however often you write. Clinicians are licensed in all fifty states, so a move or a run of work travel does not break the thread.
How often after that
After the first visit, the cadence follows your plan. If hormone therapy is started, follow-up labs typically come at six to eight weeks. Metabolic changes are rechecked at about 90 days. Beneath both runs the quarterly review: four panels a year, each read against the last, with the plan adjusted by message or a short video visit, and monthly check-ins in between when hormones are part of the plan. The practice tracks the schedule, so remembering it is not your job.
When you hear from a clinician
| Step | What happens | Timing |
|---|---|---|
| Eligibility check, intake, checkout | You answer the questions and pay $598 for the first two months | On your schedule |
| Clinician's review | Accepted into care (the first two months are then non-refundable), or not accepted and refunded in full | No guaranteed turnaround published |
| First panel | Drawn at LabCorp or Quest, sent to your clinician | Before the first visit |
| First video visit | Labs read with you, plan written | Typically 45–60 minutes |
| Messages | Asynchronous, with the care team | Typically same-day or next-day in the DPC model |
| Follow-up labs | If hormone therapy starts; if metabolic changes are made | 6–8 weeks; about 90 days |
| Quarterly review | Four panels a year, read against the last | Every three months |
What it costs, what it buys, and what it does not do
The membership is $299 a month. You pay $598 at checkout, which covers the first two months, and it is month to month after that. If the clinician cannot accept you into care, the $598 is refunded in full; once you are accepted, the first two months are non-refundable, and any medication billed by a pharmacy follows that pharmacy's own return and refund policy. The fee buys four cardiometabolic panels a year with every result in your hands, a clinician who stays, asynchronous messaging and video visits, from clinicians licensed in all fifty states. It is the same fee whatever medication is indicated and whatever the dose. If medication is indicated, it is prescribed to the pharmacy you choose at that pharmacy's own price; GoodLife Health sets nothing, sees nothing and takes nothing on it. The fee is generally eligible for HSA or FSA pre-tax dollars.
In return you get the diagnosis the short visit never produced, or clear evidence that the cause lies elsewhere; your markers followed quarter by quarter instead of glimpsed once; and the rushed visit, not repeated. The difference is the order of operations. GoodLife Health tests first and treats second, and it sells neither the drug nor the dose.
That order is also the honest answer to the thought that a testosterone clinic or an app would be faster. It may well be faster to a prescription. A model that earns on the vial is paid when the answer is yes; this one is paid the same whether your clinician's answer is testosterone, thyroid medication, something for the weight, or nothing at all. For symptoms with more than one possible cause, that is the incentive you want on the other side of the screen.
What the membership does not do matters as much. It does not promise testosterone. Testosterone is a Schedule III controlled substance; it is prescribed and dispensed only where federal and state law allow, through the clinical partner's arrangement, and only when your clinician judges it indicated. It does not promise weight loss. It does not replace your insurance, which you keep for the hospital and catastrophic care; it replaces the primary-care relationship. It does not run, speed or win prior authorizations, which are the pharmacy's process, and it cannot promise that your plan will cover a medication.
If your clinician does judge a branded GLP-1 indicated for the weight, the price belongs to the manufacturer or the pharmacy, and it is published. In September 2026, NovoCare listed Wegovy pens at $199 a month for the first two fills (an introductory offer for new patients through December 2026) and $349 a month after, and LillyDirect listed Zepbound vials at $299 to $449 a month depending on dose.
What to do this week, whichever way you decide
We cannot tell you from here what is behind your symptoms. Nobody can, from three symptoms and a panel that left out the relevant markers. What you can do this week costs nothing.
Ask your doctor's office for a copy of the results you were told were normal, and read what is on it and what is not. Look for total testosterone, free testosterone, SHBG, TSH, free T3, free T4 and fasting insulin. If any of them is absent, you now know which questions were never asked.
If testosterone is drawn anywhere, ask that it be a morning draw, and that a single result be repeated before anyone acts on it in either direction.
Write down, with rough dates, when the fatigue, the weight and the change in drive began, how you are sleeping, and everything you take. A clinician who reads that next to a panel will get further than one hearing it for the first time across a desk.
If you decide to join, the reason to do it now sits in your own situation. The symptoms are already here, the answer so far rests on tests that did not include the markers that matter for them, and the first quarterly panel is the baseline every later read is measured against. The sooner it exists, the sooner the second one tells you something.
Who this is not for
This is not for you if you want testosterone prescribed this week on the strength of how you feel; the membership never promises it, and your clinician will want the morning draw and the repeat first. It is not for you if the goal is the cheapest prescription available online at whatever cadence an app sends; the membership will feel slow and expensive, and it is better to know that before checkout. It is not for you if you need an answer within the hour, because asynchronous messaging is the wrong tool for that, and your insurance and the hospital it pays for remain the place for urgent care. It is not for you if you live outside the fifty states. And it will not suit you if you would rather not have blood drawn four times a year, because the panels are the point.
For everyone else, here is the offer in one place. It is $299 a month, with $598 charged at checkout for the first two months and month to month after. If a clinician cannot accept you, the $598 is refunded in full; once you are accepted, the first two months are non-refundable, and pharmacy-billed medication follows that pharmacy's own refund policy. It buys the quarterly panel, the clinician who stays, and medication at your pharmacy's price with nothing taken on it. It returns the markers nobody drew, followed over time. You hear first whether you are accepted, then by message, typically same-day or next-day in the usual direct primary care pattern, and at every quarterly panel after that.
Related Reading
- What a Direct Primary Care Visit Actually Looks Like (2026)
- Bioidentical Hormone Therapy at Pharmacy Cost: The Real Numbers
- Cardiometabolic optimization: the definitive guide
References
- NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
- Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings